ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
ProShares Short Midcap400 1x Shares

ProShares Short Midcap400 1x Shares (03O2)

17.422
0.09
(0.52%)
마감 23 1월 6:00AM
실시간 데이터

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

03O2 뉴스

공식 뉴스 전용
0개의 기사가 발견되었습니다.
boarddork boarddork 3 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 3 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 3 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 5 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 5 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 6 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 8 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 9 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 9 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 10 분 전
Whats 305
RNVA
theorysuit theorysuit 12 분 전
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 12 분 전
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 12 분 전
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 13 분 전
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 13 분 전
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 14 분 전
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 15 분 전
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 15 분 전
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 15 분 전
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX

최근 히스토리

Delayed Upgrade Clock